Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease.
This report contains market size and forecasts of Colorectal Cancer Screening in Global, including the following market information:
Global Colorectal Cancer Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colorectal Cancer Screening market was valued at 662.8 million in 2021 and is projected to reach US$ 782.1 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stool-based Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Screening Market Segment Percentages, by Type, 2021 (%)
Stool-based Tests
Colonoscopy
CT Colonography
Others
Global Colorectal Cancer Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Screening Market Segment Percentages, by Application, 2021 (%)
Hospitals
Independent Diagnostic Labs
Others
Global Colorectal Cancer Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colorectal Cancer Screening Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colorectal Cancer Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Clinical Genomics Technologies
Epigenomics Inc
Exact Sciences
Roche
Hemosure Inc
Novigenix SA
Quidel
Siemens
Sysmex